110 related articles for article (PubMed ID: 6253707)
21. Gc group distributions in patients with cancer.
Hughes NR
J Natl Cancer Inst; 1968 Aug; 41(2):303-11. PubMed ID: 4299536
[No Abstract] [Full Text] [Related]
22. Protein binding of itraconazole and fluconazole in patients with cancer.
Arredondo G; Calvo R; Marcos F; Martínez-Jordá R; Suarez E
Int J Clin Pharmacol Ther; 1995 Aug; 33(8):449-52. PubMed ID: 8556224
[TBL] [Abstract][Full Text] [Related]
23. The detection of quantitative serum p53 protein in lung cancer.
Sen E; Gönüllü U; Akar N
Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
[TBL] [Abstract][Full Text] [Related]
24. MIA, a novel serum marker for progression of malignant melanoma.
Bosserhoff AK; Lederer M; Kaufmann M; Hein R; Stolz W; Apfel R; Bogdahn U; Buettner R
Anticancer Res; 1999; 19(4A):2691-3. PubMed ID: 10470221
[TBL] [Abstract][Full Text] [Related]
25. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
[TBL] [Abstract][Full Text] [Related]
26. [Determination of plasma fibronectin (Fn) levels. Comparison between normal subjects and patients with various pathological conditions].
Gironi A; Niccolai J; Fabbri LP; Niccolai M; Chisci C
Quad Sclavo Diagn; 1982 Dec; 18(4):392-405. PubMed ID: 6764670
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients.
Ozkan Y; Yardim-Akaydin S; Firat H; Calişkan-Can E; Ardiç S; Simşek B
Anticancer Res; 2007; 27(2):1185-9. PubMed ID: 17465261
[TBL] [Abstract][Full Text] [Related]
28. Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer.
Gencer M; Ceylan E; Aksoy N; Uzun K
Respiration; 2006; 73(4):520-4. PubMed ID: 16432293
[TBL] [Abstract][Full Text] [Related]
29. [Electrophoretic separation of serum proteins in tumor patients].
Goriukhina TA; Cherenkovskaia IA; Sinitsina NI
Vopr Onkol; 1966 Apr; 12(4):46-50. PubMed ID: 5245208
[No Abstract] [Full Text] [Related]
30. Serum endostatin levels in patients with lung carcinoma.
Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
[TBL] [Abstract][Full Text] [Related]
31. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.
Joensuu H; Anttonen A; Eriksson M; Mäkitaro R; Alfthan H; Kinnula V; Leppä S
Cancer Res; 2002 Sep; 62(18):5210-7. PubMed ID: 12234986
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
33. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
Rucińska M; Furman M; Skrzydlewski Z; Zaremba E
Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361
[TBL] [Abstract][Full Text] [Related]
34. A clinical evaluation of serum C3DP levels in individuals with malignant diseases.
Parsons RG; Longmire RL; Hoch SO; Hoch JA
Cancer Res; 1977 Mar; 37(3):692-5. PubMed ID: 837370
[TBL] [Abstract][Full Text] [Related]
35. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
Li R; Li R; Wang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
[TBL] [Abstract][Full Text] [Related]
36. Serum midkine levels are increased in patients with various types of carcinomas.
Ikematsu S; Yano A; Aridome K; Kikuchi M; Kumai H; Nagano H; Okamoto K; Oda M; Sakuma S; Aikou T; Muramatsu H; Kadomatsu K; Muramatsu T
Br J Cancer; 2000 Sep; 83(6):701-6. PubMed ID: 10952771
[TBL] [Abstract][Full Text] [Related]
37. [Cyfra 21-1--a new tumor marker of the cytokeratin series in differential diagnosis of lung diseases].
Oremek GM; Seiffert UB; Siekmeier R; Kirsten R
Med Klin (Munich); 1995 Jan; 90(1):23-6. PubMed ID: 7533887
[TBL] [Abstract][Full Text] [Related]
38. Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia.
Werynska B; Ramlau R; Podolak-Dawidziak M; Jankowska R; Prajs I; Usnarska-Zubkiewicz L; Kuliczkowski K
Neoplasma; 2003; 50(6):447-51. PubMed ID: 14689068
[TBL] [Abstract][Full Text] [Related]
39. Serum retinoic acid, retinol and retinyl palmitate levels in patients with lung cancer.
Moulas AN; Gerogianni IC; Papadopoulos D; Gourgoulianis KI
Respirology; 2006 Mar; 11(2):169-74. PubMed ID: 16548902
[TBL] [Abstract][Full Text] [Related]
40. Detection of a serum DNA-binding protein associated with cancer.
Galvan L; Evans JE; Comis RL; Gottlieb A; Gyorkey F; Lane M; Prestayko AW; Crooke ST
Cancer Res; 1982 Apr; 42(4):1562-6. PubMed ID: 6174228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
